CTCL 06 2017

2 Pogledi
administrator
administrator
08/09/23

Description

  • Kategorija

Prikaži više
0 Komentari Poredaj po

    Nema komentara

    Komentari na Facebooku

    Sljedeći

    Aarogyamastu | Pituitary Disorders | 30th May 2017 | ఆరోగ్యమస్తు
    00:07:22
    Aarogyamastu | Pituitary Disorders | 30th May 2017 | ఆరోగ్యమస్తు
    administrator
    1 Pogledi
    Dr. ETV | Signs and symptoms of ovarian cancer | 4th January 2017 | డాక్టర్ ఈటివీ
    00:02:39
    Dr. ETV | Signs and symptoms of ovarian cancer | 4th January 2017 | డాక్టర్ ఈటివీ
    administrator
    2 Pogledi
    DTRF Patient Meeting 2017 Rachel Sitta
    00:05:35
    DTRF Patient Meeting 2017 Rachel Sitta
    administrator
    2 Pogledi
    Thomas Brittain - Living With Stage 3 Ewing Sarcoma (2017)
    00:04:18
    Thomas Brittain - Living With Stage 3 Ewing Sarcoma (2017)
    administrator
    1 Pogledi
    George's 2017 PNET Ewing Sarcoma Cancer Journey in pictures
    00:02:42
    George's 2017 PNET Ewing Sarcoma Cancer Journey in pictures
    administrator
    1 Pogledi
    CAP education session Ewing Sarcoma PNET Dr El Demellawy 2017
    01:11:10
    CAP education session Ewing Sarcoma PNET Dr El Demellawy 2017
    administrator
    3 Pogledi
    UI Stead Family Children's Hospital Kid Captain 2017: Hayden Wheatley
    00:04:19
    UI Stead Family Children's Hospital Kid Captain 2017: Hayden Wheatley
    administrator
    4 Pogledi
    Mucocele (Ahuja AT et al; 2017) Book: Essential Radiology
    00:00:26
    Mucocele (Ahuja AT et al; 2017) Book: Essential Radiology
    administrator
    1 Pogledi
    Oro-hypopharyngeal abscess (B) (Ahuja AT et al; 2017) Book: Essential Radiology ...
    00:00:33
    Oro-hypopharyngeal abscess (B) (Ahuja AT et al; 2017) Book: Essential Radiology ...
    administrator
    2 Pogledi
    Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
    00:03:06
    Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
    administrator
    3 Pogledi
    CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
    00:02:51
    CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
    administrator
    2 Pogledi
    The Importance of Collaboration in Treating CTCL (Chapter 7)
    00:02:30
    The Importance of Collaboration in Treating CTCL (Chapter 7)
    administrator
    3 Pogledi
    The CTCL diagnosis journey
    00:00:20
    The CTCL diagnosis journey
    administrator
    6 Pogledi
    Unmet needs for late-stage CTCL
    00:01:10
    Unmet needs for late-stage CTCL
    administrator
    3 Pogledi
    Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
    00:01:16
    Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
    administrator
    2 Pogledi
    Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
    00:01:35
    Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
    administrator
    4 Pogledi
    2017 Memphis PEF: Overview of Cutaneous Lymphomas Classification
    00:24:18
    2017 Memphis PEF: Overview of Cutaneous Lymphomas Classification
    administrator
    3 Pogledi
    FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
    00:08:49
    FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
    administrator
    10 Pogledi
    Pre-clinical activity of tipifarnib in CTCL
    00:02:12
    Pre-clinical activity of tipifarnib in CTCL
    administrator
    5 Pogledi